Engineered tissue grafts might assist carry out key liver features and profit hundreds of individuals residing with liver failure.
The liver is likely one of the physique’s hardest-working organs, finishing up a whole bunch of significant jobs, from filtering toxins and metabolizing drugs to producing proteins important for blood clotting. But when it fails, the one definitive remedy is usually a transplant, an answer restricted by a continual scarcity of donor organs.
MIT engineers have now developed injectable “mini livers” that, in mice, survived for at the very least two months whereas performing most of the features of wholesome liver tissue.
“We consider these as satellite tv for pc livers. If we might ship these cells into the physique, whereas leaving the sick organ in place, that would offer booster operate,” says Sangeeta Bhatia, the John and Dorothy Wilson Professor of Well being Sciences and Know-how and of Electrical Engineering and Laptop Science at MIT, and a member of MIT’s Koch Institute for Integrative Most cancers Analysis and the Institute for Medical Engineering and Science (IMES).
Bhatia is the senior writer of the examine, which was printed within the journal Cell Biomaterials. MIT postdoc Vardhman Kumar is the paper’s lead writer.
Restoring liver operate
The liver carries out about 500 important jobs, from serving to management blood clotting to clearing micro organism from the blood and breaking down medicine. Many of those duties rely upon hepatocytes, the liver’s essential useful cells.
For greater than a decade, Bhatia’s lab has been growing methods to revive hepatocyte exercise with out requiring a surgical liver transplant. One technique is to put hepatocytes inside a biomaterial equivalent to a hydrogel, however that strategy nonetheless requires surgical procedure to implant the gel.
Injecting hepatocytes straight into the physique might keep away from that surgical procedure. On this examine, Bhatia’s lab aimed to make that strategy more practical by giving the cells an engineered surroundings that would assist them survive and permit docs to trace graft well being with out one other invasive process.
The answer was to inject the cells along with hydrogel microspheres. These tiny spheres assist the cells stay clustered and join with close by blood vessels. They will behave like a liquid when packed collectively, which permits them to move by means of a syringe, then return to a stable construction as soon as contained in the physique.
In recent times, hydrogel microspheres have been studied as instruments for wound therapeutic as a result of they permit cells to maneuver into the areas between the spheres and kind new tissue. Within the new work, the MIT group tailored the identical primary thought to assist hepatocytes construct a secure graft after injection.
“What we did is use this expertise to create an engineered area of interest for cell transplantation,” Kumar says. “If the cells are injected within the absence of those spheres, they might not combine effectively with the host, however these microspheres present the hepatocytes with a distinct segment the place they will keep localized and turn into linked to the host circulation a lot quicker.”
The injected materials additionally accommodates fibroblast cells, which help hepatocyte survival and encourage blood vessels to develop into the graft.
Working with Nicole Henning, an ultrasound analysis specialist on the Koch Institute, Bhatia’s lab developed an ultrasound-guided syringe methodology to put the cell combination within the physique. The identical imaging methodology may also be used after injection to observe the implant’s stability over time.
For this examine, the mini livers had been positioned in fats tissue within the stomach. Future variations might probably be delivered to different elements of the physique, together with the spleen or areas close to the kidneys. If the graft has sufficient room and a powerful blood provide, the injected hepatocytes can act very like hepatocytes contained in the liver.
“For a overwhelming majority of liver problems, the graft doesn’t want to sit down near the liver,” Kumar says.
A substitute for transplantation
In mouse experiments, the combination of liver cells and microspheres was injected into fatty tissue referred to as perigonadal adipose tissue. After the cells settled in place, they shaped a dense and secure construction. As time handed, new blood vessels grew into the graft, serving to hold the hepatocytes alive and useful.
“The brand new blood vessels shaped proper subsequent to the hepatocytes, which is why they had been in a position to survive,” Kumar says. “They had been in a position to get the vitamins delivered proper to them, they had been in a position to operate the best way they’re speculated to, and so they produced the proteins that we count on them to.”
The cells remained alive and continued releasing specialised proteins into the animals’ circulation for eight weeks, which was the total length of the examine. That consequence suggests the strategy might in the future function a long-term remedy for liver illness, in keeping with Bhatia’s lab.
“The best way we see this expertise is it might probably present a substitute for surgical procedure, however it might probably additionally function a bridge to transplantation the place these grafts can present help till a donor organ turns into out there,” Kumar says. “And if we expect they may want one other remedy or extra grafts, the obstacles to try this are a lot much less with this injectable expertise than present process one other surgical procedure.”
With the present model of the expertise, sufferers would most likely want immunosuppressive medicine. Bhatia’s lab is now learning doable methods round that limitation, together with “stealthy” hepatocytes that would keep away from immune assault or hydrogel microspheres that launch immunosuppressants straight on the graft website.
Reference: “Picture-guided injectable area of interest for hepatocyte transplantation” by Vardhman Kumar, Joa Yun, Susanna Okay. Elledge, Nicole Henning, Katarzyna A. Grzelak, Ashley D. Westerfield, Amy Stoddard, Favour A. Oladimeji, Virginia Spanoudaki, Kasturi Chakraborty, Savan Okay. Patel, Heather E. Fleming, Christopher S. Chen and Sangeeta N. Bhatia, 3 March 2026, Cell Biomaterials.
DOI: 10.1016/j.celbio.2026.100378
